[REGN] YoY Quarter Result on 31-Mar-2016 [#Q1]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
05-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- 6.93%
YoY- 118.01%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Revenue 1,711,800 1,511,485 1,318,991 1,200,849 869,612 625,740 439,664 25.41%
PBT 546,100 585,398 432,289 330,151 276,523 175,263 141,831 25.18%
Tax 85,000 107,418 183,358 164,415 200,502 109,820 42,957 12.04%
NP 461,100 477,980 248,931 165,736 76,021 65,443 98,874 29.24%
Tax Rate -15.56% -18.35% -42.42% -49.80% -72.51% -62.66% -30.29% -
Total Cost 1,250,700 1,033,505 1,070,060 1,035,113 793,591 560,297 340,790 24.18%
Ratio Analysis
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
NP Margin 26.94 31.62 18.87 13.80 8.74 10.46 22.49 3.05%
Per Share
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
EPS 4.23 4.44 2.36 1.74 0.74 0.69 1.02 26.73%
EPS Diluted 3.99 4.16 2.16 1.59 0.66 0.61 0.90 28.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.